Hero Image Description

Drug Finder

Or Find from List:

Copanlisib

Generic name:
Copanlisib
Brand name(s), other common name(s):
AliqopaTM
Drug type:
phosphatidylinositol-3-kinase (PI3K) inhibitor
How the drug is given:
intravenously

Indications and Usage

Copanlisib is FDA approved for the treatment of adult patients with relapsed follicular lymphoma (FL) who have received at least two prior systemic therapies.

Side effects needing medical attention

High blood sugar levels (hyperglycemia), diarrhea, decreased general strength and energy, high blood pressure (hypertension), low levels of certain white blood cells (leukopenia, neutropenia), nausea, lower respiratory tract infections, and low levels of blood platelets (thrombocytopenia).

For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.